Welcome to Scribd. Sign in or start your free trial to enjoy unlimited e-books, audiobooks & documents.Find out more
Download
Standard view
Full view
of .
Look up keyword
Like this
2Activity
0 of .
Results for:
No results containing your search query
P. 1
Stock Market Updates

Stock Market Updates

Ratings:
(0)
|Views: 15|Likes:
Published by Will Rodgers


Stock market updates, stocks to watch and medical microcap stock money info news.


Stock market updates, stocks to watch and medical microcap stock money info news.

More info:

Published by: Will Rodgers on Sep 06, 2012
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

09/06/2012

pdf

text

original

 
Medical Stock NewsMedical Products Company Stock NewsSee More At:
TheMoney Info Investment News Show will featureDave Andy Sealfon of Repro-Med Systems, Inc. (Stock Symbol:REPR ).
 
Watch It Live September 6, 2012 at 6:05 PM-7:00 PM EDT
Use this Listen Live Link To Watch The Show.
A recording of the show will be available once it airs at:
BE ON THE AIR WITH USCALL IN YOUR QUESTIONS888-792-1590
The Money Info Show by Princeton Research airs every Thursday at 6:05 PM to 7:00 PM Eastern and Tuesdays 10 AM to 11AM.The Money Info Show with Mike King and Charles Moskowitz features where to invest now, stock market, business,economy and financial investment news.The September 6, 2012 show will feature a medical products company, R
epro-Med Systems, Inc. (Stock Symbol: REPR).
 Repro-Med Systems, Inc., operating as RMS Medical products, is a leading developer and manufacturer of medical devicesand supplies. Repro-Med was incorporated in March, 1980. Its stock is publicly traded in the over-the-counter market and isquoted through the National Daily Quotation Service.
 
Visit the corporate website:http://www.rmsmedicalproducts.com
RMS manufactures medical devices used in emergency care, hospital settings, nursing homes, other medical facilities andhome care. Their primary products are:
FREEDOM60®
Syringe Infusion System –
Popular for subcutaneous administration of immune globulin (SCIG)especially in the home care market it offers healthcare providers benefits for antibiotics, chemotherapeutics, painmedications, and other application uses.
FREEDOM60® Syringe Infusion Pump
- Used for the subcutaneous administration of immune globulin offers safe,controlled pressure and ability to adjust automatically to the flow. The inherently safe pressures used to deliverdrugs to patients minimize discomfort, swelling and other complications sometimes found with conventionalelectric infusion devices. There are additional applications such as the delivery of antibiotics and other drugs.
RMS HIGH-Flo™ Subcutaneous Safety Needle Sets -
RMS Successfully introduced this product to the US marketduring the 2012 fiscal year. Used with the Company's FREEDOM60® pump or pumps from other manufacturers.The Company has received feedback from some SCIG patients experiencing less pain, less infusion time, and lessdiscomfort when switching to High-Flo™.
RES-Q-VAC®
Emergency Hand Operated Suction System
- Fills a niche in emergency medicine, hospitals, and homecare for immediate airway suction when and wherever needed. RES-Q-VAC® has patented filtration to minimizeexposure of medical personnel to dangerous pathogens from patients infected with life threatening diseases suchas tuberculosis and SARS. Because RES-Q-VAC® provides reliable suction without electric power, it is useful indisasters when the electricity fails.
 
REPR also produces expendables used in conjunction with these devices.
Repro-Med Systems, Inc. has reported 29.9% Increase In Sales For Fiscal Year Ended February 29, 2012 And SuccessfulIntroduction Of The RMS High-Flo Subcutaneous Safety Needle Sets. See news release:http://finance.yahoo.com/news/repro-med-systems-inc-reports-130000821.html 
Andrew Sealfon, President and CEO of RMS Medical Products, stated,
"This year we continued the growth trend of recent years, with $6,390,534 in revenue whichrepresents an increase of 29.9% over the previous fiscal year. Our FREEDOM60® product line realizeda 31.9% increase in sales. Our net operating profit was $1,289,158 and our net income for the yearwas $815,893."
In other recent news the REPR
protecting medical workersfrom accidental needlesticks.See this news release at: http://rmsmedicalproducts.com/downloads/news/latest/HIgH-FloConfirmedAsSafetyNeedles.pdf The company maintains offices, manufacturing facilities, and warehouse space in Chester, New York. Devices and suppliesmanufactured and sold by RMS Medical Products are subject to Food and Drug Administration regulation.Their manufacturing facilities and record-keeping must meet FDA standards, and are subject to periodic FDA inspection. Inaddition, the company's plant complies with appropriate ISO international standards for quality in product development,manufacturing, distribution and customer support of its medical devices.In 2011, the company received FDA approval to market in the U.S. it's HIgH-Flo RMS Subcutaneous Needle Sets. Since 1986,the company has owned and marketed the Gyneco product line which includes the Masterson Endometrial Biopsy Kit usedfor in-office biopsy sampling procedures, and the Thermal Cautery System used for tubal ligation procedures.RMS maintains its own sales staff in addition to selling its products through distributors in the U.S. and many othercountries. It regularly exhibits at both national and international trade shows.The company holds a number of patents related to products it has developed and ismanufacturing. Because Repro-Med Systems, Inc., is a public company, it must comply with financial reporting and otherregulations established by the Securities and Exchange Commission.
For REPRstock quotes, trading charts and

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->